Pharmacological Reports

Papers
(The H4-Index of Pharmacological Reports is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience103
Hypoxia-inducible factors and essential hypertension: narrative review of experimental and clinical data97
Acknowledgments74
Potential drugs for the treatment of Alzheimer’s disease66
A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in mice63
Iodothyronine deiodinases in patients with stable chronic obstructive pulmonary disease - preliminary results63
Luteolin for neurodegenerative diseases: a review61
The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis61
Note from editors60
Novel method of measurement of in vitro drug uptake in OATP1B3 overexpressing cells in the presence of dextran59
Genetic liability for anxiety and treatment response to the monoamine stabilizer OSU6162 in alcohol dependence: a retrospective secondary analysis58
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices57
Assessing the effects of 5-HT2A and 5-HT5A receptor antagonists on DOI-induced head-twitch response in male rats using marker-less deep learning algorithms49
Evaluation of nano-curcumin against inhaled paraquat-induced lung injury in rats44
Padsevonil suppresses seizures without inducing cell death in neonatal rats44
The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations41
β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo41
The HPA axis and kynurenine pathway: exploring the role of stress and neuroinflammation in treatment-resistant depression38
Decoding the serotonin–alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder36
Association analysis of ADRB3:rs4994 with urodynamic outcome, six months after a single intra-detrusor injection of botulinum toxin, in women with overactive bladder35
The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice34
Novel receptor tyrosine kinase-targeted strategies to overcome resistance in oral squamous cell carcinoma30
Genetic variants in GRIN2B and NTRK2 on the etiology and treatment response to valproate and lithium in patients with bipolar disorder30
Pten knockout affects drug resistance differently in melanoma and kidney cancer29
Carvacrol in asthma management: a comprehensive review of its therapeutic potential and mechanisms of action29
The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds28
Prospects and challenges in intracellular delivery of therapeutic proteins28
Glutathione deficiency in the early postnatal developmental period as a neurodevelopmental animal model of schizophrenia27
0.12678098678589